Form D · Biotechnology

ACON Bios Investors, L.P.

Washington, DC · CIK 0001761493

Offering snapshot reported Dec 21, 2018 · SEC filing

Reported sold
$25M
Offering amount: $25M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 17, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 21, 2018Initial$25,000,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-328782

Source: Form D, filed Dec 21, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ACON BIOS INVESTORS, L.P.

Investment adviser: ACON LATAM MANAGEMENT, L.L.C.

Gross asset value
$301M
Beneficial owners
5
ADV minimum commitment
$500K

Reported in Form ADV on Sep 1, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SEI GLOBAL SERVICES, INC. OAKS, Pennsylvania, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor PRICEWATERHOUSECOOPERS MCLEAN, Virginia, United States
Custodian WELLS FARGO BANK, N.A. MCLEAN, Virginia, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

PRICEWATERHOUSECOOPERS
PCAOB 238

WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09

Filing source

Form ADV 2129084 · Sep 1, 2026 · Schedule D 7.B.(1), fund 805-3331994591

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Acon Bios Gen Par, L.L.C. Promoter
Teresa Y. Bernstein Executive
Jose Knoell Executive
Kwame Lewis Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1133 Connecticut Avenue, N.W., Suite 700
Washington, DC, 20036